PT - JOURNAL ARTICLE AU - van Buul, Laura W. AU - van den Besselaar, Judith H. AU - Koene, Fleur M.H.P.H. AU - Buurman, Bianca M. AU - Hertogh, Cees M.P.M. AU - , TI - Asymptomatic cases and limited transmission of SARS-CoV-2 in residents and healthcare workers in three Dutch nursing homes AID - 10.1101/2020.08.31.20185033 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.31.20185033 4099 - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185033.short 4100 - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185033.full AB - Purpose Many nursing homes worldwide have been hit by outbreaks of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to assess the contribution of a- and presymptomatic residents and healthcare workers in transmission of SARS-CoV-2 in three nursing homes.Methods Two serial point-prevalence surveys, 1 week apart, among residents and healthcare workers of three Dutch nursing homes with recent SARS-CoV-2 introduction. Nasopharyngeal and oropharyngeal testing for SARS-CoV-2, including reverse-transcriptase polymerase chain reaction (rRT-PCR) was presymptomatic or asymptomatic with standardized symptom assessment.Results In total, 297 residents and 542 healthcare workers participated in the study. At the first point-prevalence survey, 15 residents tested positive of which one was presymptomatic (Ct value>35) and three remained asymptomatic (Ct value of 23, 30 and 32). At the second point-prevalence survey one resident and one healthcare worker tested SARS-CoV-2 positive (Ct value >35 and 24, respectively) and both remained asymptomatic.Conclusion This study confirms a-and presymptomatic occurrence of Covid-19 among residents and health care workers. Ct values below 25 suggested that these cases have the potential to contribute to viral spread. However, very limited transmission impeded the ability to answer the research question. We describe factors that may contribute to the prevention of transmission and argue that the necessity of large-scale preemptive testing in nursing homes may be dependent of the local situation regarding prevalence of cases in the surrounding community and infection control opportunities.Aim To assess the contribution of a- and presymptomatic residents and healthcare workers in transmission of SARS-CoV-2 in three nursing homes by facility wide preemptive testing.Findings Occurrence of a-and presymptomatic residents and healthcare workers with Ct values below 25 was confirmed. However, evaluation of contribution to transmission of the virus was not possible because of limited positive cases in the follow-up.Message Necessity of large-scale preemptive testing for a- and presymptomatic SARS-CoV-2 cases in nursing homes may be dependent on prevalence of cases in the surrounding community and infection control opportunities.Competing Interest StatementThis work was supported by the National Institute for Public Health and the Environment (Dutch: RIVM), Bilthoven, the Netherlands.Funding StatementThis work was supported by the National Institute for Public Health and the Environment (Dutch: RIVM), Bilthoven, the Netherlands.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Medical Ethics Committee of the Amsterdam University Medical Centre reviewed the study protocol and confirmed that the study does not fall under the scope of the Medical Research Involving Human Subjects Act.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on request